
Hormone therapy and its effect on hair medication
Hormone therapy changes the androgen environment that drives pattern hair loss, so it interacts directly with hair-loss treatment.
Hormone therapy changes the androgen environment that drives pattern hair loss, so it interacts directly with hair-loss treatment. Anyone on hormone therapy of any kind should have their hair plan built around it rather than alongside it.
Why do hormone therapy and hair-loss medication interact?
Pattern hair loss depends on androgen action at the follicle, so anything that changes circulating androgens, or the balance between androgens and oestrogens, changes the pressure on susceptible follicles. Hormone therapy is therefore not a background detail to a hair-loss plan; it is part of the plan itself.
What situations bring hormone therapy and hair-loss treatment together?
Five situations commonly bring the two together: menopausal hormone therapy, hormonal contraception (progestogens vary in androgenic activity), testosterone therapy (which raises the substrate for DHT and can accelerate pattern loss), gender-affirming hormone therapy, and anti-androgen therapy, which may itself improve scalp hair.
- Menopausal hormone therapy, where changing oestrogen levels affect hair alongside other symptoms
- Hormonal contraception, where different progestogens differ in androgenic activity
- Testosterone therapy, which raises the substrate for DHT and can accelerate pattern loss in susceptible people
- Gender-affirming hormone therapy, where the intended effects include changes to hair growth
- Anti-androgen therapy, which may itself improve scalp hair
How should the timing of hormone therapy be managed around hair treatment?
Starting or changing hormone therapy shortly before assessing a hair treatment makes it impossible to attribute the result to either one. Where hormone therapy is expected to change hair, it is usually sensible to let it stabilise first, before judging a hair-loss treatment or planning surgery, since loss trajectory shapes the surgical plan.
Who should be involved when planning hormone therapy alongside hair-loss treatment?
The clinician managing your hormone therapy should be involved, not just the hair clinic, because anti-androgens used for hair loss, such as Spironolactone, carry their own interactions and contraindications. Disclose all of it at consultation, since a surgeon planning a hairline needs to know if your androgen environment is about to change.
Hormonal causes of hair loss are covered separately under causes of hair loss.
Sources
- Vano-Galvan S, et al. Safety of low-dose oral Minoxidil for hair loss: A multicenter study of 1404 patients. Journal of the American Academy of Dermatology, 2021. pubmed.ncbi.nlm.nih.gov/33639244
This article summarises published research. It is general educational information, not medical advice, and it is not a recommendation to start, stop or change any medication. Prescription drugs carry contraindications and interactions; discuss them with a doctor who knows your medical history.
Get a no-obligation assessment against fixed criteria, directly on WhatsApp.